Literature DB >> 9083969

Echocardiographic assessment of mitral stenosis and its associated valvular lesions in 205 patients and lack of association with mitral valve prolapse.

A Sagie1, N Freitas, M H Chen, J E Marshall, A E Weyman, R A Levine.   

Abstract

To date, the relation between mitral stenosis (MS) and other associated cardiac valvular lesions has been reported by angiography and surgical pathologic study in patients with more advanced disease but has not been studied systematically by two-dimensional echocardiography and Doppler color flow mapping in a large referral population with a broader spectrum of severity. In addition, prior reports have suggested that up to 40% of patients with MS have mitral valve prolapse (MVP); however, because of recent developments in two-dimensional echocardiographic imaging and the definition of MVP, this association must now be reconsidered. The purpose of this study was to explore the association of other valvular lesions with MS and their relation to its severity and in particular to test whether MS is in fact associated with MVP with the frequency reported previously. We reviewed the studies of 205 consecutive patients (aged 61 +/- 14 years; range 26 to 87 years) with MS who were studied from 1992 to 1994 by two-dimensional echocardiography and Doppler color flow mapping to assess valvular stenosis, regurgitation, and MVP in patients with a range of severity of MS (28% mild, 34% moderate, and 38% severe MS based on mitral valve area). MS was associated with at least mild mitral regurgitation in 78% of patients (160/205), and pure MS was correspondingly uncommon (22%). There was an inverse relationship between the severity of MS and the degree of mitral regurgitation (p < 0.001). MS was frequently associated (54% of patients) with significant lesions of other valves, including aortic stenosis (17%), at least moderate aortic regurgitation (8%) and tricuspid regurgitation (38%), and tricuspid stenosis (4%). Tricuspid stenosis was associated with more severe MS (p < 0.01), and tricuspid regurgitation was more common in patients with mixed MS and regurgitation than in those with pure stenosis (60% versus 26% for at least moderate tricuspid regurgitation; p < 0.001). Mitral valve prolapse was present in only one patient (0.5%). Superior systolic bulging of the midportion of the anterior mitral leaflet toward the left atrium (but not superior to the annular hinge points) was seen in 22 patients (11%). Patients with such superior bulging had significantly lower mitral valve scores but a similar degree of mitral regurgitation compared with those without bulging. The majority of patients with MS (78%) have associated mitral regurgitation and significant lesions of the other cardiac valves (54%). The frequency of true MVP associated with chronic MS is much lower than reported previously. This may provide insight into the underlying pathophysiologic process, tending to shorten the chordae tendineae and leaflets to produce stenosis rather than elongate them to produce prolapse.

Entities:  

Mesh:

Year:  1997        PMID: 9083969     DOI: 10.1016/s0894-7317(97)70086-5

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  9 in total

Review 1.  Echocardiographic assessment and clinical management of tricuspid regurgitation.

Authors:  Nicole M Bhave; R Parker Ward
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

Review 2.  Evidence-based surgical management of acquired tricuspid valve disease.

Authors:  Sung Ho Shinn; Hartzell V Schaff
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

3.  [Current standard in diagnosis and therapy of heart valve lesions].

Authors:  S Reith; H Körtke; O Volk; H G Klues
Journal:  Z Kardiol       Date:  2001-12

Review 4.  Tricuspid Valve Percutaneous Therapies.

Authors:  Bhaskar Bhardwaj; Joaquin E Cigarroa; Firas Zahr
Journal:  Curr Cardiol Rep       Date:  2022-06-29       Impact factor: 3.955

Review 5.  Current Unmet Needs and Clues to the Solution in the Management of Tricuspid Regurgitation.

Authors:  Byung Joo Sun; Jae-Hyeong Park
Journal:  Korean Circ J       Date:  2022-06       Impact factor: 3.101

6.  Criteria for determining the need for surgical treatment of tricuspid regurgitation during mitral valve replacement.

Authors:  Jigang He; Zhenya Shen; Yunsheng Yu; Haoyue Huang; Wenxue Ye; Yinglong Ding; Shaolei Yang
Journal:  J Cardiothorac Surg       Date:  2012-03-25       Impact factor: 1.637

7.  Presence of ´isolated´ tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction.

Authors:  Julia Mascherbauer; Andreas A Kammerlander; Caroline Zotter-Tufaro; Stefan Aschauer; Franz Duca; Daniel Dalos; Susanne Winkler; Matthias Schneider; Jutta Bergler-Klein; Diana Bonderman
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

8.  Tricuspid regurgitation in ischemic mitral regurgitation patients: prevalence, predictors for outcome and long-term follow-up.

Authors:  Ofir Koren; Henda Darawsha; Ehud Rozner; Daniel Benhamou; Yoav Turgeman
Journal:  BMC Cardiovasc Disord       Date:  2021-04-21       Impact factor: 2.298

9.  Rheumatic mitral stenosis in children: more accelerated course in sub-Saharan patients.

Authors:  Henok Tadele; Wubegzier Mekonnen; Endale Tefera
Journal:  BMC Cardiovasc Disord       Date:  2013-11-01       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.